EAFVX | VIVIX | EAFVX / VIVIX | |
Total Expense Ratio | 0.99 | 0.04 | 2,475% |
Annual Report Gross Expense Ratio | 1.06 | 0.04 | 2,650% |
Fund Existence | 15 years | 27 years | - |
Gain YTD | 6.633 | 10.748 | 62% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 5000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 240M | 208B | 0% |
Annual Yield % from dividends | 1.06 | 2.09 | 51% |
Returns for 1 year | 0.07 | 8.21 | 1% |
Returns for 3 years | 24.83 | 49.10 | 51% |
Returns for 5 years | 39.48 | 73.42 | 54% |
Returns for 10 years | 64.67 | 132.88 | 49% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBMPX | 142.92 | N/A | N/A |
Fidelity Select Communication Services | |||
STSEX | 2713.73 | N/A | N/A |
BlackRock Exchange BlackRock | |||
FRBRX | 163.85 | N/A | N/A |
Franklin Biotechnology Discovery R6 | |||
PRCGX | 26.77 | N/A | N/A |
Perritt MicroCap Opportunities Investor | |||
MLAAX | 11.02 | -0.07 | -0.63% |
NYLI Winslow Large Cap Growth Class A |